Listed

Emergent BioSolutions Inc.: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 3, 2018 and accepted by EDGAR at Aug 2, 2018, 17:55 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-04-01 to 2018-06-30$220.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2018-01-01 to 2018-06-30$338.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2018-04-01 to 2018-06-30$89.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-01-01 to 2018-06-30$147.2mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2018-04-01 to 2018-06-30$24.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$53.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-04-01 to 2018-06-30$39.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-01-01 to 2018-06-30$79.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-04-01 to 2018-06-30$66.8mus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30$57.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2018-04-01 to 2018-06-30$1.0mus-gaap:InterestExpense
Interest expense6 months2018-01-01 to 2018-06-30$1.2mus-gaap:InterestExpense
Income tax3 months2018-04-01 to 2018-06-30$15.7mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30$11.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30$50.1mus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30$45.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30$0.98us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30$0.89us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-04-01 to 2018-06-30$1.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2018-01-01 to 2018-06-30$0.91us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-04-01 to 2018-06-3051,162,909 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2018-01-01 to 2018-06-3051,039,195 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2018-01-01 to 2018-06-30$33.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-01-01 to 2018-06-30$25.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2018-01-01 to 2018-06-30$145.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-06-30$190.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-06-30$541.3mus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$1.14bnus-gaap:Assets
Current liabilitiesAt period end2018-06-30$96.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$200.5mus-gaap:Liabilities
Long-term debtAt period end2018-06-30$13.5mus-gaap:LongTermDebtNoncurrent

Source: SEC EDGAR, the filing index for accession 0001367644-18-000033. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.